American Well Corporation faces a precarious outlook as it struggles to transition its legacy platform to the Converge model, evidenced by a 22.1% year-over-year revenue decline in 2025Q4. The company's inability to achieve positive operating income, coupled w...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 4, 2026 | -$0.59+31.4% vs -$0.86 | $52M+4.4% vs $50M |
Q2 2026 May 5, 2026 | -$0.66+14.3% vs -$0.77 | $55M+6.5% vs $52M |
Q1 2026 Feb 12, 2026 | -$1.43+10.1% vs -$1.59 | $55M+5.1% vs $53M |
Q4 2025 Nov 4, 2025 | -$1.74-19.4% vs -$1.46 | $56M+3.2% vs $55M |
American Well Corporation (AMWL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
Benchmark AMWL against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for American Well Corporation (AMWL)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $13.21 | $224.69M | -2.22 | -1.98% | -38.38% | -33.93% | — | |
| $6.13 | $1.11B | -5.38 | -1.54% | -7.13% | -13.08% | — | |
| $26.57 | $4.97B | 27.11 | 13.05% | 25.48% | 16.95% | — | |
| $28.39 | $6.33B | 55.67 | 59% | -5.51% | -30.03% | — | |
| $7.60 | $142.61M | 28.15 | 18.78% | 4.66% | 3.6% | — | |
| $5.25 | $879.44M | 131.25 | 22% | 0.08% | 0.17% | — |
American Well Corporation (AMWL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
American Well Corporation (AMWL) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 4, 2026·SEC
Jul 21, 2026·SEC
Jul 14, 2026·SEC
Get notified when AMWL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
American Well Corporation (AMWL) stock FAQ — growth, dividends, profitability & financials explained
American Well Corporation (AMWL) reported $218.5M in revenue for fiscal year 2025. This represents a 92% increase from $114.0M in 2018.
American Well Corporation (AMWL) saw revenue decline by 2.0% over the past year.
American Well Corporation (AMWL) reported a net loss of $78.1M for fiscal year 2025.
American Well Corporation (AMWL) has a return on equity (ROE) of -33.9%. Negative ROE indicates the company is unprofitable.
American Well Corporation (AMWL) had negative free cash flow of $23.6M in fiscal year 2025, likely due to heavy capital investments.
